www.hivandhepatitis.com

Back HCV Disease Progression

EASL 2016: Sofosbuvir/ Ledipasvir for 6 Weeks Cures Acute Hepatitis C in HIV-Negative People

Details
Category: Acute Hepatitis C
Published on Sunday, 17 April 2016 00:00
Written by Liz Highleyman
  • Print

A regimen of sofosbuvir/ledipasvir (Harvoni) taken for 6 weeks cured all patients with genotype 1 acute hepatitis C virus (HCV) infection, including those with high viral loads, according to findings from a German study presented this week at the 2016 EASL International Liver Congress in Barcelona. The researchers said treating hepatitis C early with a short regimen would improve symptoms sooner, prevent HCV transmission, and cost less than treatment initiated during chronic infection.

alt

Read more:

More Articles...

  1. EASL 2016: Hepatitis C Treatment May Not Stop Progression to Advanced Liver Disease
  2. CROI 2016: Harvoni for 6 Weeks Cures HIV+ People with Acute HCV if Viral Load is Low
  3. AASLD 2015: Sofosbuvir Plus Ribavirin Shows Suboptimal Efficacy for Acute Hepatitis C
  4. AASLD 2015: Clinical Impact of DAAS -- Referrals for Liver Transplants Drop
  5. Coverage of the 2015 AASLD Liver Meeting

Subcategories

Copyright © 2025 www.hivandhepatitis.com. All Rights Reserved. Designed by JoomlArt.com. Joomla! is Free Software released under the GNU General Public License.

Bread and Roses Web DesignWeb Design and Development by Bread and Roses Web Design